Skip to main content
. 2021 Dec 21;14(1):4. doi: 10.3390/cancers14010004

Figure 2.

Figure 2

(A) DNA methylation of BRCA1, CST6, MGMT, RASSF10, SLFN11 and USP44 gene promoters in primary tumors of patients diagnosed with early (FIGO I-II) and advanced stage (FIGO III) HGSOC. (B) DNA methylation of BRCA1, SLFN11 and USP44 gene promoters in plasma cfDNA of patients diagnosed with advanced (FIGO III) and metastatic stage (FIGO IV) HGSOC.